Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-18

Clinical Trial Update: Chepetsa TB - Reducing TB Among HIV-Infected Malawians [NA]

View source ↗

Summary

Clinical trial update on Chepetsa TB aiming to reduce tuberculosis among HIV-infected Malawians. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis | NA | Status: COMPLETED